The Global Personal Accident and Health Insurance market is significantly driven by rising awareness about health risks and the increasing prevalence ...

Analyst David Windley of Jefferies maintained a Buy rating on UnitedHealth (UNH – Research Report), reducing the price target to $609.00.Invest ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

The article discusses the impact of recent events on the insurance industry, focusing on UnitedHealth. Read more.

Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...

We remain comfortable with our slightly higher EPS expectation for UnitedHealth, absent another unusual event.